Abaxis, Inc. (NASDAQ:ABAX)
CAPS Rating:
The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.
RSS Headlines
Fool UK
Recs
Abaxis has seen its glory days. I've watched this stock climb from $4-5 per share up to over $20. Unless they come up with something new, they will be relying on their reagent discs to supply income.